netter-1 update: 177lu-dotatate in patients with midgut neuroendocrine tumors
Published 3 years ago • 390 plays • Length 1:59Download video MP4
Download video MP3
Similar videos
-
4:25
final os from netter-1: lutetium-177-dotatate in patients with midgut nets
-
23:34
netter 1 phase iii in patients with midgut neuroendocrine tumors treated with 177lu dotatate efficac
-
1:57
177lu-dotatate in patients with well-differentiated, high-grade nets
-
2:58
netter-1: radioactive octreotide effective in metastatic neuroendocrine tumors
-
2:16
dr. strosberg on quality of life findings for lu-dotatate in patients with midgut nets
-
1:41
dr. jonathan r. strosberg on 177-lu-dotatate in patients with neuroendocrine tumors
-
1:19
dr. strosberg on future of 177lu-dotatate therapy in neuroendocrine tumors
-
2:03
dr. strosberg on the results of the netter-1 trial
-
5:52
netter-1 clinical trial overview
-
1:36
dr. strosberg on netter-1 trial results for midgut nets
-
1:25
dr. jonathan r. strosberg on the netter-1 trial and its impact on patients with midgut nets
-
23:22
netter-1: targeted radionuclide therapy improves pfs in mid-gut nets
-
8:03
ecc 2015: netter-1 trial showed rare cancer responded unusually well to new treatment
-
42:10
clinical nuclear medicine | prrt, lutathera and netter 1 trial
-
1:43
dr. strosberg discusses updates from the netter-1 study
-
2:16
dr. strosberg on quality of life for midgut neuroendocrine tumors
-
5:47
mid-gut nets respond to targeted radionuclide therapy: netter-1 results
-
0:48
netter-2: 177lu-dotatate in gastroenteropancreatic nets
-
5:00
netter-1: phase iii efficacy and safety results in patients...